Boostrix® Pregnancy Registry for Boostrix® Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed This is a Pregnancy Registry for Boostrix vaccine (GSK) approved and marketed in the United States. GSK is collaborating with OTIS/ MotherToBaby Research Center for the Boostrix Pregnancy Registry. The Registry relies on voluntary reporting of pregnancy and exposures by women and health care providers (HCPs) who contact OTIS/MotherToBaby Pregnancy Studies, or the MotherToBaby network. The Registry is a research program and helps us gain further knowledge on Boostrix use during pregnancy.
To participate in this registry: enrolment in the registry is open to pregnant women living in the US and should take place before the outcome of pregnancy is known.
For pregnant women:
For health providers: As of date 20th of June, HCPs or pregnant women, who reside in US, looking at the GSK Boostrix Pregnancy Registry website or calling the telephone number that is included in the GSK package labeling for Boostrix in the US (1-888-452-9622) should be re-directed to Otis/ MotherToBaby pregnancy studies.
GlaxoSmithKline's Boostrix® Pregnancy Registry is managed by:
About MotherToBaby Pregnancy Studies | Learn More Additional resources: Complete Prescribing Information is provided in Adobe's Portable Document Format (PDF). To view these documents, you will need Adobe Acrobat Reader; if you do not have it, follow the link below to download a copy. If you are unable to or do not wish to download Acrobat Reader, but still wish to receive complete Prescribing Information, please click here. |
|